Silence Therapeutics Plc (SLNCF)
4.00
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Silence Therapeutics Cash and Short Term Investments (Quarterly) : 72.05M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.05M |
| March 31, 2026 | 70.08M |
| December 31, 2025 | 85.11M |
| September 30, 2025 | 102.19M |
| June 30, 2025 | 114.16M |
| March 31, 2025 | 136.53M |
| September 30, 2024 | 173.02M |
| June 30, 2024 | 189.10M |
| March 31, 2024 | 192.97M |
| Date | Value |
|---|---|
| December 31, 2023 | 68.88M |
| September 30, 2023 | 71.78M |
| June 30, 2023 | 63.85M |
| March 31, 2023 | 77.73M |
| December 31, 2022 | 85.58M |
| September 30, 2022 | 100.49M |
| June 30, 2022 | 62.62M |
| March 31, 2022 | 78.07M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 25.89M |
| Mereo BioPharma Group Plc | 30.12M |
| Compass Pathways Plc | 433.72M |
| HemoGenyx Pharmaceuticals Plc | -- |